Wendy D. Jones

Wendy D. Jones

Auto-generated profile, based on publicly available information

Wendy D. Jones

North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children, London, UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2018 in Science
Verified
Journal Article
Closed access
PDF file
HMHilary C. Martin
Hilary C. Martin
WJWendy D. Jones
Wendy D. Jones
RMRebecca McIntyre
Rebecca McIntyre
GSGabriela Sanchez-Andrade
Gabriela Sanchez-Andrade
MSMark Sanderson
Mark Sanderson
OSon behalf of the Deciphering Developmental Disorders Study
on behalf of the Deciphering Developmental Disorders Study
Genetic architecture of developmental disorders: The genetics of developmental disorders (DDs) is complex. Martin et al. wanted to determine the degree of recessive inheritance of DDs in protein-coding genes. They examined the exomes of more than 6000 families in populations with high and low proportions of consanguineous marriages. They found that 3.6% of DDs in individuals of European ancestry involved recessive coding disorders, less than a tenth of the levels previously estimated. Furthermore, among South Asians with high parental relatedness, rather than most of the disorders arising from inherited variants, fewer than half had a recessive coding diagnosis. Science , this issue p. 1161

8 February 2013 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
PDF file
JNJared Nathanson
Jared Nathanson
DSDaniel T. Swarr
Daniel T. Swarr
ASAmihood Singer
Amihood Singer
MLMochi Liu
Mochi Liu
ACAmy Chinn
Amy Chinn
ASAnne Slavotinek
Anne Slavotinek
Loss of function mutations in FREM1 have been demonstrated in Manitoba‐oculo‐tricho‐anal (MOTA) syndrome and Bifid Nose Renal Agenesis and Anorectal malformations (BNAR) syndrome, but the wider phenotypic spectrum that is associated with FREM1 mutations remains to be defined. We screened three probands with phenotypic features of MOTA syndrome. In one severely affected infant who was diagnosed with MOTA syndrome because of bilateral eyelid colobomas, a bifid nasal tip, hydrometrocolpos and vaginal atresia, we found two nonsense mutations that likely result in complete loss of FREM1 function. This infant also had renal dysplasia, a finding more consistent with BNAR syndrome. Another male who was homozygous for a novel stop mutation had an extensive eyelid colobomas, corneopalpebral synechiae, and unilateral renal agenesis. A third male child diagnosed with MOTA syndrome because of corneopalpebral synechiae and eyelid colobomas had a homozygous splice site mutation in FREM1. These cases illustrate that disruption of the FREM1 gene can produce a spectrum of clinical manifestations encompassing the previously described MOTA and BNAR syndromes, and that features of both syndromes may be seen in the same individual. The phenotype of FREM1‐related disorders is thus more pleiotropic than for MOTA and BNAR syndrome alone and more closely resembles the widespread clinical involvement seen with Fraser syndrome. Moreover, our first case demonstrates that vaginal atresia may be a feature of FREM1‐related disorders.

24 October 2024 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
Angela PeronAngela Peron
Angela Peron
FDFelice D’arco
Felice D’arco
KAKimberly A. Aldinger
Kimberly A. Aldinger
CSConstance Smith-Hicks
Constance Smith-Hicks
CZChristiane Zweier
Christiane Zweier
T(Telethon Undiagnosed Disease Program (Tudp)
Telethon Undiagnosed Disease Program (Tudp)
An increasing number of individuals with intellectual developmental disorder (IDD) and heterozygous variants in BCL11A are identified, yet our knowledge of manifestations and mutational spectrum is lacking. To address this, we performed detailed analysis of 42 individuals with BCL11A-related IDD (BCL11A-IDD, a.k.a. Dias-Logan syndrome) ascertained through an international collaborative network, and reviewed 35 additional previously reported patients. Analysis of 77 affected individuals identified 60 unique disease-causing variants (30 frameshift, 7 missense, 6 splice-site, 17 stop-gain) and 8 unique BCL11A microdeletions. We define the most prevalent features of BCL11A-IDD: IDD, postnatal-onset microcephaly, hypotonia, behavioral abnormalities, autism spectrum disorder, and persistence of fetal hemoglobin (HbF), and identify autonomic dysregulation as new feature. BCL11A-IDD is distinguished from 2p16 microdeletion syndrome, which has a higher incidence of congenital anomalies. Our results underscore BCL11A as an important transcription factor in human hindbrain development, identifying a previously underrecognized phenotype of a small brainstem with a reduced pons/medulla ratio. Genotype-phenotype correlation revealed an isoform-dependent trend in severity of truncating variants: those affecting all isoforms are associated with higher frequency of hypotonia, and those affecting the long (BCL11A-L) and extra-long (-XL) isoforms, sparing the short (-S), are associated with higher frequency of postnatal microcephaly. With the largest international cohort to date, this study highlights persistence of fetal hemoglobin as a consistent biomarker and hindbrain abnormalities as a common feature. It contributes significantly to our understanding of BCL11A-IDD through an extensive unbiased multi-center assessment, providing valuable insights for diagnosis, management and counselling, and into BCL11A’s role in brain development.

11 May 2023 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SLSunwoo Lee
Sunwoo Lee
LMLara Menzies
Lara Menzies
EHEleanor Hay
Eleanor Hay
EOEguzkine Ochoa
Eguzkine Ochoa
FDFrance Docquier
France Docquier
EMEamonn Richard Maher
Eamonn Richard Maher
Germline pathogenic variants in two genes encoding the lysine-specific histone methyltransferase genes SETD1A and SETD2 are associated with neurodevelopmental disorders (NDDs) characterized by developmental delay and congenital anomalies. The SETD1A and SETD2 gene products play a critical role in chromatin-mediated regulation of gene expression. Specific methylation episignatures have been detected for a range of chromatin gene-related NDDs and have impacted clinical practice by improving the interpretation of variant pathogenicity. To investigate if SETD1A and/or SETD2-related NDDs are associated with a detectable episignature, we undertook targeted genome-wide methylation profiling of > 2 M CpGs using a next-generation sequencing-based assay. A comparison of methylation profiles in patients with SETD1A variants (n = 6) did not reveal evidence of a strong methylation episignature. A review of the clinical and genetic features of the SETD2 patient group revealed that, as reported previously, there were phenotypic differences between patients with truncating mutations (n = 4, Luscan-Lumish syndrome; MIM:616831) and those with missense codon 1740 variants [p.Arg1740Trp (n = 4) and p.Arg1740Gln (n = 2)]. Both SETD2 subgroups demonstrated a methylation episignature, which was characterized by hypomethylation and hypermethylation events, respectively. Within the codon 1740 subgroup, both the methylation changes and clinical phenotype were more severe in those with p.Arg1740Trp variants. We also noted that two of 10 cases with a SETD2-NDD had developed a neoplasm. These findings reveal novel epigenotype–genotype–phenotype correlations in SETD2-NDDs and predict a gain-of-function mechanism for SETD2 codon 1740 pathogenic variants.

6 September 2022 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
AVAthina Ververi
Athina Ververi
SZSara Zagaglia
Sara Zagaglia
LMLara Menzies
Lara Menzies
JBJulia Baptista
Julia Baptista
RCRichard Caswell
Richard Caswell
JHJane A Hurst
Jane A Hurst
DEPDC5 (DEP Domain-Containing Protein 5) encodes an inhibitory component of the mammalian target of rapamycin (mTOR) pathway and is commonly implicated in sporadic and familial focal epilepsies, both non-lesional and in association with focal cortical dysplasia. Germline pathogenic variants are typically heterozygous and inactivating. We describe a novel phenotype caused by germline biallelic missense variants in DEPDC5. Cases were identified clinically. Available records, including magnetic resonance imaging and electroencephalography, were reviewed. Genetic testing was performed by whole exome and whole-genome sequencing and cascade screening. In addition, immunohistochemistry was performed on skin biopsy. The phenotype was identified in nine children, eight of which are described in detail herein. Six of the children were of Irish Traveller, two of Tunisian and one of Lebanese origin. The Irish Traveller children shared the same DEPDC5 germline homozygous missense variant (p.Thr337Arg), whereas the Lebanese and Tunisian children shared a different germline homozygous variant (p.Arg806Cys). Consistent phenotypic features included extensive bilateral polymicrogyria, congenital macrocephaly and early-onset refractory epilepsy, in keeping with other mTOR-opathies. Eye and cardiac involvement and severe neutropenia were also observed in one or more patients. Five of the children died in infancy or childhood; the other four are currently aged between 5 months and 6 years. Skin biopsy immunohistochemistry was supportive of hyperactivation of the mTOR pathway. The clinical, histopathological and genetic evidence supports a causal role for the homozygous DEPDC5 variants, expanding our understanding of the biology of this gene.

2 November 2020 in Livestock
Verified
Journal Article
Open access
NNNicola Noble
Nicola Noble
FOFrancesca Occhiuto
Francesca Occhiuto
FLFiona Margaret Lovatt
Fiona Margaret Lovatt
MJMarion Johnson
Marion Johnson
WJWendy Jones
Wendy Jones
JKJasmeet Kaler
Jasmeet Kaler
Sheep farming is an important part of UK agriculture with significantly more breeding females than either the pig or cattle sectors. Whether grazing alongside arable rotations or utilising the marginal uplands, sheep farms arguably play a key role that is embedded within UK rural society. However, research led by University of Nottingham has identified various challenges and barriers that have affected relationships between UK sheep farmers and the veterinary profession. In response to these findings, Flock Health Clubs were developed as an initiative that aimed for improved and cost-effective sheep farmer–veterinary interaction. We report quantitative and qualitative data that assess the impact of Flock Health Clubs and indeed show tangible improvements in both farmer–veterinary surgeon relationships and measures of flock health and welfare.